A Swediah biopharma company developing live biotherapeutic products for diseases affecting premature infants, led by IBP-9414 ...

Merck & Co (NYSE: MRK) and Johnson & Johnson (NYSE: JNJ) were pharma's big buyers in M&A during November. They were joined by ...

The chronic kidney disease (CKD)-hyperparathyroidism (HPT), hyperphosphatemia (HP), and hyperkalemia (HK) market across the ...

US biotech Regeneron Pharmaceuticals and Tessera Therapeutics have entered into a global collaboration to develop and ...

The European Investment Bank (EIB) and Angelini Ventures—the Italian drugmaker’s corporate venture capital fund—have signed ...

US biotech Citius Oncology (Nasdaq: CTOR) has launched Lymphir (denileukin diftitox-cxdl), its first commercial product, ...

Trimtech Therapeutics, a UK biotech developing novel small molecule therapies that target and degrade protein aggregates ...

The accelerated approval pathway has long represented one of the US Food and Drug Administration’s (FDA) most important tools ...

Axoltis Pharma, a French biotech company dedicated to developing novel therapeutic solutions for neurodegenerative diseases, ...

US pharma major Eli Lilly (NYSE: LLY) has lowered the price of Zepbound (tirzepatide) single-dose vials on its Lilly Direct ...

Biopharma company Reig Jofre has consolidated its stake in Leanbio, a fellow Barcelona-based firm focused on the design, ...

The Association for Accessible Medicines (AAM) has welcomed House passage of Q1/Q2 legislation embedded in the Give Kids a ...